Newsroom

WASHINGTON--(BUSINESS WIRE)--The 2025 Top 25 Historic Hotels of America® Most Magnificent Gingerbread Displays List Is Announced...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 09.12.2025 KNG.LN IE000SNMGYT5 200,002.00 USD 4,035,158.64 20.176  ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive data from the Phase III lidERA Breast Cancer study evaluating investigational giredestrant as an adjuvant endocrine treatment for people with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2-negative, early-stage breast cancer. At the pre-specified interim analysis, adjuvant giredestrant significantly reduced the risk of invasive di...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 09.12.2025 GNOV LN IE000OJ31JQ4 1,250,002.00 USD 43,506,106.87 34.805  ...

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--MED Institute and Sus Clinicals partner to advance preclinical testing, accelerating innovation and improving outcomes for medical products....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 09.12.2025 GAUG LN IE000TGSG3Y5 650,002.00 USD 22,775,697.27 35.039  ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor TUKYSA® (tucatinib) as part of an investigational first-line maintenance treatment combination, following chemotherapy-based induction, in patients with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC). The primary endpoint analysis showed a 35.9% reduction in the risk of disease progression or death amon...

MINNETONKA, Minn. & REHOVOT, Israel--(BUSINESS WIRE)--Powered by Stratasys (NASDAQ: SSYS) technology, Airbus is producing more than 25,000 flight-ready 3D-printed parts annually, transforming how aircraft are built and maintained across its global fleet. Evolving from its first part, a spare crew seat component, Airbus has embraced additive manufacturing, taking it to new heights with more than 200,000 certified Stratasys polymer parts now in active service. Recent data shows that the implement...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 09.12.2025 SCAR LN IE000BW2B3J3 25,002.00 USD 658,716.00 26.347  ...